{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:58:28Z","timestamp":1773215908133,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.urolonc.2019.09.024","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T09:26:11Z","timestamp":1574155571000},"page":"43.e13-43.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival"],"prefix":"10.1016","volume":"38","author":[{"given":"Till","family":"Eichenauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Bannenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Wittmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"B\u00fcscheck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Dum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Fraune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Hube-Magg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"M\u00f6ller-Koop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Dahlem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Fisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Riechardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Christina","family":"Tsourlakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bernreuther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Minner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Wilczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till S.","family":"Clauditz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2019.09.024_bib0001","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0002","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00345-018-2286-7","article-title":"Epidemiology and screening for renal cancer","volume":"36","author":"Rossi","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0003","doi-asserted-by":"crossref","first-page":"15698","DOI":"10.1038\/s41598-017-15922-4","article-title":"Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries","volume":"7","author":"Wong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0004","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","article-title":"European Association of Urology guidelines on renal cell carcinoma: the 2019 update","volume":"75","author":"Ljungberg","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0005","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0006","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1200\/JCO.2016.70.7398","article-title":"Cabozantinib Versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the alliance A031203 CABOSUN trial","volume":"35","author":"Choueiri","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0007","series-title":"National Cancer Institute, Renal Cell Cancer Treatment (PDQ(R)): Health Professional Version. PDQ Cancer Information Summaries","year":"2002"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0008","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.79.0147","article-title":"Prognostication in kidney cancer: recent advances and future directions","volume":"36","author":"Graham","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0009","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1038\/oncsis.2012.14","article-title":"Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation","volume":"1","author":"Moore","year":"2012","journal-title":"Oncogenesis"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1097-0215(19990105)80:1<22::AID-IJC5>3.0.CO;2-S","article-title":"Microsatellite analysis reveals deletion of a large region at chromosome 8p in conventional renal cell carcinoma","volume":"80","author":"Schullerus","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0011","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00345-011-0783-z","article-title":"Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma","volume":"31","author":"Eichelberg","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0012","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","article-title":"Tissue microarrays for high-throughput molecular profiling of tumor specimens","volume":"4","author":"Kononen","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0013","doi-asserted-by":"crossref","first-page":"379","DOI":"10.18632\/oncotarget.13425","article-title":"Deletion of 8p is an independent prognostic parameter in prostate cancer","volume":"8","author":"Kluth","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0014","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajpath.2012.04.026","article-title":"Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer","volume":"181","author":"Krohn","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0015","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1200\/JCO.2007.15.8345","article-title":"Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma","volume":"27","author":"Klatte","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0016","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1349-7006.2000.tb00927.x","article-title":"Molecular cytogenetic analysis of 17 renal cancer cell lines: increased copy number at 5q31-33 in cell lines from nonpapillary carcinomas","volume":"91","author":"Yang","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0017","first-page":"7731","article-title":"Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis","volume":"61","author":"Gunawan","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0018","first-page":"6200","article-title":"Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors","volume":"63","author":"Gunawan","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0019","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/path.2239","article-title":"High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma","volume":"213","author":"Yoshimoto","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0020","first-page":"3636","article-title":"Chromosomal imbalances revealed in primary renal cell carcinomas by comparative genomic hybridization","volume":"8","author":"Kang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0021","first-page":"27","article-title":"Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma","volume":"56","author":"Moch","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0022","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/00365590310025399","article-title":"Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma","volume":"38","author":"Kallio","year":"2004","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000056987","article-title":"Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization","volume":"93","author":"Reutzel","year":"2001","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/428325","article-title":"A comprehensive study of progressive cytogenetic alterations in clear cell renal cell carcinoma and a new model for ccRCC tumorigenesis and progression","volume":"2010","author":"Zhang","year":"2010","journal-title":"Adv Bioinformatics"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<151::AID-PATH928>3.0.CO;2-R","article-title":"Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas","volume":"183","author":"Schullerus","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0026","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0022-5347(05)65346-3","article-title":"Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney","volume":"167","author":"Presti","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0027","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2559.2004.01884.x","article-title":"Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes","volume":"44","author":"Nagy","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0028","first-page":"6189","article-title":"Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology","volume":"55","author":"Thrash-Bingham","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0029","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1470-2045(03)01225-7","article-title":"Chromosome arm 8p and cancer: a fragile hypothesis","volume":"4","author":"Birnbaum","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0031","first-page":"6111","article-title":"Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression","volume":"60","author":"Bowen","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0032","first-page":"123","article-title":"Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer","volume":"5","author":"Hornstein","year":"2008","journal-title":"Cancer Genom Proteom"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0033","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1101\/gad.1672608","article-title":"DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma","volume":"22","author":"Xue","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0034","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1007\/s13277-013-1581-6","article-title":"Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0035","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1158\/1055-9965.EPI-09-0864","article-title":"Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men","volume":"19","author":"Beuten","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0036","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ccr.2013.01.002","article-title":"Integrative genomic analyses reveal androgen-driven somatic alteration landscape in early-onset prostate cancer","volume":"23","author":"Weischenfeldt","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0037","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature09744","article-title":"The genomic complexity of primary human prostate cancer","volume":"470","author":"Berger","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0038","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0039","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0040","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1073\/pnas.1206062109","article-title":"A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions","volume":"109","author":"Xue","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0041","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1080\/15384047.2015.1046025","article-title":"8p deletion is strongly linked to poor prognosis in breast cancer","volume":"16","author":"Lebok","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0042","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1002\/cncr.10612","article-title":"High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation","volume":"94","author":"Chan","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0043","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/cncr.10254","article-title":"Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma","volume":"94","author":"Kusano","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0044","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cgh.2006.07.010","article-title":"Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization","volume":"4","author":"Steinemann","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0045","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3748\/wjg.v11.i20.3034","article-title":"Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China","volume":"11","author":"Zhang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0046","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/jmg.37.5.342","article-title":"Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer","volume":"37","author":"Sigbjornsdottir","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0047","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccell.2016.04.003","article-title":"Loss of chromosome 8p governs tumor progression and drug response by altering lipid metabolism","volume":"29","author":"Cai","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0048","first-page":"1973","article-title":"Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer","volume":"59","author":"Wistuba","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0049","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2407-8-187","article-title":"Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level","volume":"8","author":"Macartney-Coxson","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0050","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1158\/0008-5472.CAN-04-3461","article-title":"Reduced FEZ1\/LZTS1 expression and outcome prediction in lung cancer","volume":"65","author":"Nonaka","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0051","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/labinvest.3700068","article-title":"Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer","volume":"84","author":"Stoehr","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0052","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/modpathol.2008.104","article-title":"Clinical significance of p53 alterations in surgically treated prostate cancers","volume":"21","author":"Schlomm","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0053","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.eururo.2014.06.027","article-title":"TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer","volume":"66","author":"Steurer","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.09.024_bib0054","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-4608(95)00030-S","article-title":"Y chromosome loss detected by FISH in bladder cancer","volume":"82","author":"Sauter","year":"1995","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919303758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919303758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:18:04Z","timestamp":1761041884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143919303758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1078143919303758"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.09.024","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}